Actionable insights straight to your inbox




Get Equities to your inbox how you want it.

Please Select Your Interests

Corporate Strategy

The company is responding to the rising cost of goods and freight.

Contributor Commentary

Two of the biggest acquisitions in the industry confirm a trend in pharma M&A: The big players are trawling for opportunities in the rare-disease space.
What a lot of investors are waiting for, I believe, is a sign that business travel has fully bounced back. Leisure travel has safely returned to 2019 levels, whereas business travel continues to trail.